PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...

Calla Lily Clinical Care has dosed the first patients in its Freedom clinical trial, a nihr‑funded study evaluating the ...

Boehringer Ingelheim has reported positive topline results from the phase III SYNCHRONIZE‑1 trial, showing that its ...

UCB has entered a new multi‑project strategic alliance with Cancer Research UK and its innovation arm, Cancer Research ...

Palisade Bio has released further phase 1a/b analyses of its investigational PDE4 inhibitor prodrug PALI‑2108, adding new ...

The study, sponsored jointly by MimiVax and Roswell Park, is led by principal investigator Dr Jasmeet Kaur.

The conversation about AI in pharmacovigilance has typically focused on automating individual steps in the case processing ...

Mid-size pharmaceutical companies operate in one of the most complex environments in healthcare. They pursue innovative ...

BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...

Omron has appointed Virendra Shelar as Executive Officer, President and CEO of Omron Europe. He will be based at the ...

There is a growing disconnect between what the industry is offering in terms of digital customer experience and what ...

There is a deceptively simple question at the heart of the English NHS – and one that frequently baffles pharma clients at HSJ Information: who is actually in charge? For much of its history, the ...